secretion and slows disease progression, but the efficacy of HWI in human ADPKD is
uncertain. Methods This exploratory, prospective, crossover study of ADPKD subjects (n= 7)
evaluated the hypothesis that HWI slows the rate of increase in height-adjusted total kidney
volume (ht-TKV; a biomarker for ADPKD progression) and reduces pain. Subjects at high
risk of ADPKD progression (ie, Mayo Imaging Classifications 1C/1D) were evaluated during …